IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer

Go back to IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer
(NASDAQ: IDYA) Delayed: 38.86 --0 (-0%)
Previous Close $38.86    52 Week High
Open $38.86    52 Week Low
Day High $38.86    P/E N/A 
Day Low $38.86    EPS
Volume 35